Biostax Corp (BTAX)

[locicat1]

It seems to me that IMUN has to file an 8-K delineating the detailed particulars of " The amended and restated license agreement (with Cytocom, Inc. in 2014) was entered in conjunction with a stock purchase agreement where the Company agreed to acquire 10% of Cytocom's issued and outstanding common stock in exchange for cancellation of approximately $ 4,100,000 of debt owed by Cytocom to the Company." The details should include when the company provided those monies.